Genetics plays a increasingly important role in the diagnosis, prevention and treatment of cancer. Genetic information can be used to identify individuals at high risk of developing cancer, to inform preventative measures and to optimize and personalize drug therapy.
Follow the links below to learn about how genetic testing can be used to personalize or optimize medical treatment and drug therapy, when testing is appropriate and access to testing in your province.
- Advanced Colorectal Cancer, KRASAccess Testing
- Hereditary Non-Polyposis Colorectal Cancer (HNPCC)Access Testing
- Tumor Screening for HNPCC, IHC, MSIAccess Testing
- Familial Adenomatous Polyposis, APCAccess Testing
- MYH-Associated Polyposis, MYHAccess Testing
- Hereditary Breast and Ovarian Cancer, BRCA1/BRCA2Access Testing
- Breast Cancer, Oncotype DX®Access Testing
- Tyrosine Kinase Inhibitor Response, BCR-ABL MonitoringAccess Testing
- Irinotecan Response, UGT1A1Access Testing
- Tamoxifen Drug Response, CYP2D6Access Testing
- Thiopurine Drug Response, TPMTAccess Testing
- 5-Fluorouracil (5-FU) Drug Response, DPD DeficiencyAccess Testing